Trial Profile

A 56-Day , Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Assess the Effect of Lorcaserin Hydrochloride on Energy Metabolism and Food Intake in Overweight and Obese Patients (TULIP).

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 13 Sep 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

02 Nov 2015 Results of post-hoc analysis of data from this trial will be presented at the ObesityWeek 2015 hosted by The Obesity Society and the American Society for Metabolic and Bariatric Surgery, according to an Eisai Co Ltd media release.
18 Jan 2011 Planned number of patients changed from 56 to 57.
11 Nov 2010 Energy intake and appetite outcomes were reported at the 2010 Annual Meeting of the North American Association for the Study of Obesity.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com